Skip to main content
UniHealth

Doctor search

Bahar Aghighi, MD

Endocrinology · Los Altos

NPI 1770562134

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
2
2 carriers
Offices
6

Offices

6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Plans that list them

2 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aghighi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

2 of 2 plans

Plans whose provider directory lists this clinician
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A61454 · Current

Licensed to practise in California · since 1997 · expires 2029-01-31 · National University of Iran Faculty of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Original Medicare doctor bills

$173,104

Medicare paid this office $173,104 for 235 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, denosumab, 1 mg43$84,939None
Return visit (30+ min)185$32,653$108
Long return visit (40+ min)26$4,742$169
New patient visit (60+ min)17$3,230$190
Fine needle aspiration biopsy using ultrasound guidance, first growth19$2,687$134
See all 8 services
Every Original Medicare service billed
Injection, denosumab, 1 mg43$84,939None
Return visit (30+ min)185$32,653$108
Long return visit (40+ min)26$4,742$169
New patient visit (60+ min)17$3,230$190
Fine needle aspiration biopsy using ultrasound guidance, first growth19$2,687$134
Injection of drug or substance under skin or into muscle47$1,612$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report20$1,543$30
Short return visit (20+ min)11$710$65

Who their Medicare patients are

235 Original Medicare patients in 2024. Average age 75 · Women 82% · Also on Medicaid 11% · Health risk score 0.98. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 59% · Diabetes 27% · Chronic kidney disease 17% · Coronary heart disease 16% · Depression 16% · Cancer 15% · Atrial fibrillation 11% · COPD 9% · Heart failure 6% · Stroke 5%.

The office billed $487,498, Medicare allowed $224,799 and paid $173,104; for 9,243 services of 14 kinds; $123,061 of it was for drugs given in the office and $50,044 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242359,243750.98$487,498$173,104
20232318,028741.02$439,093$152,812
202223111,398750.96$473,427$159,761
20212517,141740.96$393,959$135,069
20202333,442731.05$302,582$96,435
20192203,346731.17$273,114$79,277
20182032,830741.22$283,533$74,170
20172021,946721.22$260,344$68,748
2016174774721.16$185,072$47,654
201598500691.02$116,109$30,600
201436114710.94$22,401$6,255
2013294904711.14$227,869$57,262

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Original Medicare services billed in 2023
Injection, denosumab, 1 mg42$82,715None
Return visit (30+ min)187$33,760$112
Long return visit (40+ min)27$4,912$169
Fine needle aspiration biopsy using ultrasound guidance, first growth16$2,118$132
Injection of drug or substance under skin or into muscle45$1,453$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report21$1,318$31

2022: 8 services

Original Medicare services billed in 2022
Injection, denosumab, 1 mg39$63,703None
Return visit (30+ min)166$26,250$109
Long return visit (40+ min)24$4,354$161
New patient visit (60+ min)22$3,540$161
New patient visit (45+ min)18$2,859$159
Fine needle aspiration biopsy using ultrasound guidance, first growth12$1,604$134
Injection of drug or substance under skin or into muscle45$1,520$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report19$1,093$31

2021: 8 services

Original Medicare services billed in 2021
Injection, denosumab, 1 mg37$59,035None
Return visit (30+ min)167$29,041$114
New patient visit (60+ min)35$7,024$201
Long return visit (40+ min)37$6,723$156
New patient visit (45+ min)28$4,047$145
Fine needle aspiration biopsy using ultrasound guidance, first growth16$2,377$140
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report23$1,916$32
Injection of drug or substance under skin or into muscle40$1,091$14

2020: 11 services

Original Medicare services billed in 2020
Injection, denosumab, 1 mg33$42,417None
Return visit (30+ min)152$24,186$94
New patient visit (45+ min)41$5,991$146
Long return visit (40+ min)35$4,841$127
Telephone medical discussion with physician, 21-30 minutes31$4,398$102
Fine needle aspiration biopsy using ultrasound guidance, first growth26$3,304$127
New patient visit (60+ min)15$2,640$176
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report20$1,988$33
Injection of drug or substance under skin or into muscle35$833$14
Telephone medical discussion with physician, 11-20 minutes11$810$74
Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes20$352$14

2019: 8 services

Original Medicare services billed in 2019
Injection, denosumab, 1 mg31$42,902None
Return visit (30+ min)143$17,543$91
New patient visit (45+ min)46$6,744$147
Long return visit (40+ min)28$3,618$121
Fine needle aspiration biopsy using ultrasound guidance, first growth23$2,955$123
New patient visit (60+ min)16$2,890$181
Injection of drug or substance under skin or into muscle32$930$17
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report20$918$32

2018: 7 services

Original Medicare services billed in 2018
Injection, denosumab, 1 mg25$33,699None
Return visit (30+ min)142$18,951$88
New patient visit (45+ min)68$9,298$137
Fine needle aspiration using imaging guidance30$6,282$140
Long return visit (40+ min)19$2,549$127
Ultrasonic guidance for needle placement30$1,646$51
Injection of drug or substance under skin or into muscle25$824$21

2017: 7 services

Original Medicare services billed in 2017
Return visit (30+ min)153$27,209$92
Injection, denosumab, 1 mg16$18,722None
New patient visit (45+ min)63$8,988$143
Fine needle aspiration using imaging guidance27$6,523$139
Long return visit (40+ min)25$3,249$120
Ultrasonic guidance for needle placement27$1,583$57
Injection of drug or substance under skin or into muscle16$620$26

2016: 6 services

Original Medicare services billed in 2016
Return visit (30+ min)116$20,196$91
New patient visit (45+ min)79$11,415$144
Fine needle aspiration using imaging guidance23$5,406$139
Long return visit (40+ min)22$3,055$133
Ultrasonic guidance for needle placement23$1,589$59
Short return visit (20+ min)13$844$60

2015: 4 services

Original Medicare services billed in 2015
Return visit (30+ min)64$13,099$96
New patient visit (45+ min)53$8,121$153
Fine needle aspiration using imaging guidance19$3,740$139
Ultrasonic guidance for needle placement19$1,247$59

2014: 2 services

Original Medicare services billed in 2014
Return visit (30+ min)22$2,755$95
New patient visit (45+ min)13$1,973$152

2013: 6 services

Original Medicare services billed in 2013
Return visit (30+ min)204$29,398$78
New patient visit (45+ min)52$6,749$130
Ultrasonic guidance for needle placement25$4,717$168
Fine needle aspiration using imaging guidance25$3,273$117
Short return visit (20+ min)54$2,744$44
Injection of drug or substance under skin or into muscle11$435$22

Drugs they prescribed that Part D paid

$499,914

Pharmacies billed $499,914 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 1,449) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

749 generic and 648 brand-name prescriptions · $499,914 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Mounjaro78$105,105$1,347
Ozempic58$90,444$1,559
Jardiance43$69,105$1,607
Trulicity34$50,488$1,485
Synjardy Xr15$24,160$1,611
See all 26 drugs
Every Part D drug this clinician prescribed
Mounjaro78$105,105$1,347
Ozempic58$90,444$1,559
Jardiance43$69,105$1,607
Trulicity34$50,488$1,485
Synjardy Xr15$24,160$1,611
Farxiga27$18,272$677
Synthroid113$12,222$108
Tresiba Flextouch U-10019$8,779$462
Novolog Flexpen21$4,717$225
Levothyroxine281$3,200$11
Nano 2nd Gen Pen Needle23$2,578$112
Alendronate145$1,548$11
Liothyronine37$1,281$35
Levoxyl22$1,004$46
Ultra-Fine Mini Pen Needle12$950$79
Rosuvastatin44$675$15
Humulin R13$453$35
Humulin N13$453$35
Metformin Hcl Er41$309$8
Metformin61$301$5
Glipizide Er11$143$13
Atorvastatin45$139$3
Lisinopril12$131$11
Amlodipine Besylate19$59$3
Glipizide13$46$4
Dexamethasone14$12$1

Year by year

Part D prescribing by year
20241,4492240% (0)45%$499,914
20231,3512140% (0)46%$544,713
20221,3112010% (0)50%$636,951
20211,4212130% (0)51%$683,758
20201,1371930% (0)50%$424,592
20199941750% (0)53%$367,576
20181,0781600% (0)55%$385,238
20171,1941460% (0)56%$373,082
2016870132None46%$169,183
20156521170% (0)50%$142,716
20141,2672030% (0)52%$228,679
20132,5082530% (0)51%$368,581

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 24 drugs

Part D drugs prescribed in 2023
Ozempic74$137,616$1,860
Trulicity74$105,057$1,420
Jardiance53$84,891$1,602
Novolog Flexpen31$32,955$1,063
Synthroid93$11,310$122
Tresiba Flextouch U-10013$9,818$755
Lantus Solostar13$5,961$459
Levothyroxine272$4,818$18
Cytomel11$3,616$329
Nano 2nd Gen Pen Needle22$2,894$132
Humulin N11$1,758$160
Humulin R11$1,758$160
Alendronate129$1,669$13
Liothyronine29$1,420$49
Levoxyl31$706$23
Metformin Hcl Er48$700$15
Atorvastatin57$514$9
Hydrocortisone13$425$33
Metformin50$424$8
Rosuvastatin19$379$20
Lisinopril16$252$16
Glipizide16$171$11
Losartan12$139$12
Amlodipine Besylate11$113$10

2022: 28 drugs

Part D drugs prescribed in 2022
Ozempic99$171,995$1,737
Jardiance70$100,153$1,431
Trulicity58$92,272$1,591
Forteo14$53,245$3,803
Novolog Flexpen25$35,756$1,430
Tymlos12$30,475$2,540
Farxiga14$16,520$1,180
Lantus Solostar29$14,491$500
Humalog Kwikpen U-10012$11,314$943
Synthroid87$9,601$110
Novolog Mix 70-30 Flexpen11$5,381$489
Nano 2nd Gen Pen Needle26$3,790$146
Levothyroxine171$3,450$20
Humulin N12$1,899$158
Humulin R12$1,899$158
Liothyronine24$1,834$76
Ultra-Fine Mini Pen Needle13$1,756$135
Alendronate140$1,335$10
Levoxyl47$1,181$25
Rosuvastatin11$584$53
Glipizide Er19$568$30
Metformin Hcl Er47$566$12
Atorvastatin59$505$9
Metformin50$255$5
Lisinopril12$168$14
Methimazole13$167$13
Amlodipine Besylate12$79$7
Glipizide15$75$5

2021: 33 drugs

Part D drugs prescribed in 2021
Trulicity95$114,983$1,210
Ozempic63$93,838$1,489
Jardiance70$91,074$1,301
Novolog Flexpen32$54,443$1,701
Forteo11$43,145$3,922
Humalog Kwikpen U-10024$29,715$1,238
Lantus Solostar35$24,949$713
Tresiba Flextouch U-10022$22,550$1,025
Synthroid92$10,868$118
Humalog12$8,697$725
Lantus14$8,676$620
Basaglar Kwikpen U-10020$8,574$429
Farxiga11$8,301$755
Insulin Lispro Kwikpen U-10012$5,954$496
Levothyroxine151$3,837$25
Nano 2nd Gen Pen Needle19$3,047$160
Ultra-Fine Mini Pen Needle19$2,254$119
Humulin N13$2,057$158
Humulin R13$2,057$158
Liothyronine28$1,958$70
Armour Thyroid19$1,412$74
Levoxyl45$1,411$31
Ultra-Fine Nano Pen Needle13$1,368$105
Alendronate131$1,177$9
Atorvastatin56$894$16
Metformin Hcl Er62$893$14
Rosuvastatin13$646$50
Glipizide Er15$442$29
Metformin38$290$8
Prednisone11$274$25
Gabapentin13$180$14
Methimazole11$169$15
Glipizide12$58$5

2020: 25 drugs

Part D drugs prescribed in 2020
Forteo23$84,189$3,660
Trulicity41$53,454$1,304
Jardiance51$44,294$869
Novolog Flexpen36$37,769$1,049
Ozempic17$21,614$1,271
Lantus Solostar34$19,884$585
Humalog Kwikpen U-10022$15,725$715
Tradjenta25$14,862$594
Tresiba Flextouch U-10018$13,624$757
Synthroid100$11,163$112
Basaglar Kwikpen U-10011$5,069$461
Levothyroxine148$4,000$27
Ultra-Fine Nano Pen Needle31$3,131$101
Ultra-Fine Mini Pen Needle23$2,993$130
Liothyronine25$1,358$54
Levoxyl34$1,292$38
Alendronate95$984$10
Atorvastatin48$879$18
Rosuvastatin18$692$38
Armour Thyroid12$549$46
Metformin Hcl Er39$481$12
Ezetimibe11$383$35
Metformin32$308$10
Glipizide Er11$182$17
Methimazole13$99$8

2019: 25 drugs

Part D drugs prescribed in 2019
Forteo25$86,532$3,461
Humalog Kwikpen U-10053$51,976$981
Novolog Flexpen41$32,657$797
Lantus Solostar35$23,482$671
Trulicity19$23,216$1,222
Victoza 3-Pak16$18,767$1,173
Levemir Flextouch16$12,061$754
Bydureon14$9,906$708
Synthroid92$9,550$104
Jardiance11$7,392$672
Tresiba Flextouch U-10012$6,914$576
Basaglar Kwikpen U-10018$5,535$308
Ultra-Fine Nano Pen Needle36$3,401$94
Levothyroxine120$3,150$26
Ultra-Fine Mini Pen Needle21$2,395$114
Liothyronine21$1,380$66
Levoxyl37$1,360$37
Alendronate101$947$9
Rosuvastatin11$685$62
Metformin Hcl Er37$509$14
Atorvastatin31$365$12
Glipizide16$291$18
Metformin27$255$9
Methimazole14$155$11
Glipizide Er11$143$13

2018: 27 drugs

Part D drugs prescribed in 2018
Humalog Kwikpen U-10067$45,951$686
Forteo13$42,715$3,286
Victoza 3-Pak23$30,819$1,340
Novolog Flexpen44$30,622$696
Lantus Solostar48$26,423$550
Trulicity19$17,933$944
Bydureon21$15,652$745
Levemir Flextouch24$15,295$637
Toujeo Solostar14$13,292$949
Humalog13$12,949$996
Jardiance17$12,775$751
Januvia15$12,411$827
Basaglar Kwikpen U-10025$7,472$299
Synthroid80$7,438$93
Ultra-Fine Nano Pen Needle52$3,983$77
Levothyroxine111$2,852$26
Ultra-Fine Mini Pen Needle31$2,742$88
Rosuvastatin20$1,459$73
Liothyronine16$1,131$71
Levoxyl32$847$26
Metformin Hcl Er59$622$11
Alendronate73$591$8
Metformin35$369$11
Glipizide Er13$281$22
Atorvastatin23$259$11
Glipizide12$178$15
Methimazole18$164$9

2017: 27 drugs

Part D drugs prescribed in 2017
Victoza 3-Pak49$46,295$945
Lantus Solostar75$30,825$411
Novolog Flexpen50$29,479$590
Humalog Kwikpen U-10055$28,971$527
Humalog12$23,283$1,940
Androgel21$20,848$993
Humulin R U-500 Kwikpen12$20,230$1,686
Trulicity27$18,722$693
Januvia23$17,364$755
Levemir Flextouch33$13,373$405
Jardiance18$9,514$529
Tradjenta16$7,438$465
Tresiba Flextouch U-10012$6,686$557
Toujeo Solostar12$6,639$553
Synthroid70$5,033$72
Lantus11$3,769$343
Levothyroxine121$3,130$26
Ultra-Fine Mini Pen Needle38$2,507$66
Ultra-Fine Nano Pen Needle44$2,141$49
Rosuvastatin19$1,635$86
Raloxifene12$1,118$93
Liothyronine21$849$40
Alendronate91$503$6
Metformin Hcl Er63$502$8
Levoxyl16$334$21
Atorvastatin27$333$12
Metformin32$300$9

2016: 20 drugs

Part D drugs prescribed in 2016
Victoza 3-Pak25$23,950$958
Lantus Solostar59$22,200$376
Novolog Flexpen41$19,607$478
Humalog Kwikpen U-10036$16,667$463
Humalog12$16,491$1,374
Levemir Flextouch18$8,502$472
Tradjenta15$6,806$454
Synthroid63$4,319$69
Bd Ultra-Fine Pen Needle66$3,558$54
Levothyroxine86$2,116$25
Liothyronine22$554$25
Gabapentin19$374$20
Levoxyl21$361$17
Metformin Hcl Er30$349$12
Metformin34$289$8
Alendronate41$239$6
Atorvastatin36$238$7
Simvastatin18$145$8
Estradiol11$79$7
Amlodipine Besylate12$67$6

2015: 17 drugs

Part D drugs prescribed in 2015
Humulin R U-50014$32,193$2,300
Lantus Solostar62$23,295$376
Victoza 3-Pak27$18,611$689
Novolog Flexpen36$15,159$421
Levemir Flextouch25$11,118$445
Humalog Kwikpen U-10029$9,524$328
Synthroid62$4,443$72
Bd Ultra-Fine Pen Needle52$2,846$55
Liothyronine27$1,258$47
Levothyroxine49$1,238$25
Atorvastatin15$345$23
Metformin27$181$7
Metformin Hcl Er20$157$8
Losartan11$123$11
Gabapentin13$89$7
Simvastatin14$89$6
Estradiol11$56$5

2014: 33 drugs

Part D drugs prescribed in 2014
Lantus Solostar79$30,303$384
Humalog71$29,780$419
Humulin R12$29,219$2,435
Januvia32$18,788$587
Novolog Flexpen44$14,832$337
Lantus54$13,266$246
Victoza 3-Pak23$12,930$562
Synthroid170$10,817$64
Levemir Flexpen17$6,412$377
Novolog16$4,977$311
Bd Ultra-Fine Pen Needle79$3,986$50
Lovaza15$3,130$209
Liothyronine27$1,760$65
Levothyroxine66$1,546$23
Cytomel17$1,079$63
Ibandronate13$915$70
Insulin23$846$37
Atorvastatin26$823$32
Insulin23$778$34
Metformin67$749$11
Novofine 3213$669$51
Simvastatin33$336$10
Losartan16$316$20
Metformin Hcl Er27$213$8
Terazosin16$185$12
Carvedilol12$176$15
Methimazole14$148$11
Amlodipine Besylate14$138$10
Glimepiride13$133$10
Lisinopril18$119$7
Gabapentin13$113$9
Alendronate16$102$6
Hydrochlorothiazide14$45$3

2013: 44 drugs

Part D drugs prescribed in 2013
Humalog111$45,438$409
Lantus Solostar109$36,174$332
Novolog Flexpen108$34,965$324
Januvia64$29,118$455
Lantus93$27,668$298
Humulin R23$20,063$872
Synthroid368$18,948$51
Levemir Flexpen67$17,843$266
Victoza 3-Pak33$17,382$527
Novolog24$11,450$477
Byetta15$7,066$471
Crestor27$6,880$255
Bd Ultra-Fine Pen Needle135$6,029$45
Androgel14$5,114$365
Liothyronine69$4,683$68
Fenofibrate21$3,362$160
Diovan12$2,886$241
Atorvastatin57$2,199$39
Levothyroxine126$2,079$17
Metformin122$1,972$16
Ibandronate22$1,944$88
Pioglitazone13$1,822$140
Insulin56$1,629$29
Insulin33$1,334$40
Levoxyl57$1,324$23
Valsartan-Hydrochlorothiazide11$1,320$120
Simvastatin68$1,164$17
Cytomel18$881$49
Metformin Hcl Er39$832$21
Losartan41$829$20
Desmopressin Acetate12$749$62
Carvedilol35$669$19
Calcitriol23$551$24
Alendronate34$506$15
Pravastatin22$474$22
Gabapentin26$418$16
Methimazole27$355$13
Lisinopril42$328$8
Glimepiride34$277$8
Amlodipine Besylate20$267$13
Omeprazole12$197$16
Terazosin16$179$11
Atenolol12$94$8
Hydrochlorothiazide11$65$6

Money from drug and device companies

$246 in 2025

Industry payments by year
202522None$246
202311None$83
201911None$12

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Corcept TherapeuticsKorlym$125
1 payment
  • Meals for Korlym · 2025-07-14 · $125
Ascendis Pharma EndocrinologyYorvipath$122
1 payment
  • Meals for Yorvipath · 2025-04-05 · $122
See all 2 published payments
Every published payment
Corcept TherapeuticsMeals · 2025-07-14Korlym$125
Ascendis Pharma EndocrinologyMeals · 2025-04-05Yorvipath$122
See earlier years (2023, 2019)

2023: $83

Payments by company in 2023
Beta BionicsIlet Bionic Pancreas$83
1 payment
  • Meals for Ilet Bionic Pancreas · 2023-07-28 · $83

2019: $12

Payments by company in 2019
MannkindAfrezza$12
1 payment
  • Meals for Afrezza · 2019-04-17 · $12

Professional record

NPI
1770562134
Licence
CA A61454California A61454: Current · expires 2029-01-31
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RE0101X (207RE0101X)
Mailing address
2025 Soquel Ave, Santa Cruz, CA, 95062
NPI first listed
2006-01-13
NPI last updated
2011-09-14

This is when the NPI record was last certified, not a medical board exam.